TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

FDA Approval Summary: Belzutifan for Patients with Advanced Renal Cell Carcinoma.

Jaleh Fallah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.